AMD's Instinct MI325X smiles for the camera: 256 GB of HBM3E
At its CES exposition, AMD demonstrated its latest Instinct MI325X accelerator for AI and HPC workloads, which also happens ...
AMD invests $20M in AI-powered drug discovery company Absci
Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...
Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery
Million Equity Investment from AMD Strengthens Absci’s Leadership in AI Drug Discovery and Further Expands Biopharma Adoption of AMD Instinct Accelerators and ROCm SoftwareVANCOUVER, Wash., Jan. 08, ...
Absci Announces Strategic Collaboration With AMD To Advance AI-Driven Drug Discovery
Absci Corporation (ABSI), a Washington-based biotechnology company, Wednesday has announced a strategic collaboration with AMD to ...
Absci, AMD announce collaboration, strategic investment
Absci Corporation (ABSI) announced a strategic collaboration with AMD (AMD) to deploy AMD Instinct accelerators and ROCm software to power ...
Absci stock soars on AMD partnership and investment
Investing.com -- Shares of Absci Corporation (NASDAQ: ABSI) soared 50% following the announcement of a strategic ...
Benzinga.com7d
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
AMD makes a $20 million investment to boost drug research. The partnership will leverage AMD Instinct accelerators and ROCm software to support Absci’s advanced de novo antibody design models.
Yahoo Finance7d
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
The partnership will leverage AMD Instinct accelerators and ROCm software to support Absci’s advanced de novo antibody design models. The deal also includes a $20 million private investment in ...